Prostate News Archive
01-Apr-2008
Cell Genesys, Japan's Takeda to develop prostate-cancer therapy (Reuters via Yahoo! Singapore News)
March 31 - Biotechnology company Cell Genesys Inc and Japan's Takeda Pharmaceutical Co Ltd said they will develop and market Cell Genesys' prostate-cancer therapy that is currently in late-stage clinical development. Genetic overlap: Diabetes, prostate cancer (UPI)
Three teams of U.S. and European scientists working together have found six new genes that play a role in diabetes. Prostate Cancer Support Group to Meet April 9: Judith.Bennett@snhmc.org (The Nashua Telegraph)
Nashua, NH--The Prostate Cancer Support Group is pleased to announce that it will hold its April 9 meeting at Southern New Hampshire Medical Center's Health & Education Building, 10 Prospect St. beginning at 7:00 pm. The group meets on the 2nd Wednesday of every month from 7:00-8:15 pm. ... - Judith Bennett Takeda Pact No Cure-All for Cell Genesys (TheStreet.com)
The deal doesn't change the fact that the clinical data backing GVAX prostate to date come from uncontrolled studies. In other words, it's not very reliable, Adam Feuerstein says.
Back to Prostate News Archive
